Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2008 | 2017 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1994 | 1996 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2018 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2018 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
transmembrane BAX inhibitor motif containing 4 | 0.743 | 0.500 | 3.9E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 |